MCL1

(redirected from Mcl-1)

MCL1

A gene on chromosome 11q21 that encodes an anti-apoptotic protein of the Bcl-2 family.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Alvocidib is a small molecule inhibitor of cyclin-dependent kinase 9 (CDK9) that controls the expression of a survival factor MCL-1, while Venetoclax is a small molecule inhibitor of B-cell lymphoma-2 (BCL-2).
The binding of myeloid leukemia cell-differentiation protein-1 (Mcl-1), an antiapoptotic protein of the Bcl-2 family, to proapoptotic proteins, such as Bas, Bid, or Bak, inhibits apoptosis [19].
We proposed that the pathogen induces a prosurvival signalling pathway through the induction of expression of antiapoptotic factors, including myeloid cell leukemia-1 (Mcl-1), an antiapoptotic protein of the Bcl-2 family.
The researchers have discovered that that they could exploit a small portion of the protein, called MCL-1, to make a molecular tool that hindered MCL-1's "pro-survival" action.
It is understood patients with a large number of the family's Mcl-1 proteins in their blood typically have a shorter lifespan than those without.
Alvocidib is a small molecule inhibitor of cyclin-dependent kinase 9, which controls the expression of a survival factor, MCL-1. Venetoclax is a small molecule inhibitor of B-cell lymphoma-2 (BCL-2).
The product is a small molecule inhibitor of cyclin-dependent kinase 9 (CDK9), which controls the expression of a survival factor, MCL-1. Venetoclax is a small molecule inhibitor of B-cell lymphoma-2 (BCL-2).
The team led by Dr Andrew Aplin, an associate professor of Cancer Biology at Jefferson Medical College of Thomas Jefferson University, has discovered a protein called Mcl-1 that plays a critical role in melanoma cell resistance to a form of apoptosis called anoikis.
M2 EQUITYBITES-May 29, 2015-Beryllium starts development of MCL-1 platform